Cannabix Technologies said that the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for patent application No. 3243445 entitled, “Contact-Free Breath Analysis Device and Method” to the company. Recently the U.S. Patent and Trademark Office issued a notice of allowance for the same patent application filed in the United States.
A notice of allowance indicates that the patent application has been approved by an examiner and that the company can move forward with obtaining the patent granted upon payment of certain fees fee within a specified timeframe.
This patent application is centered on innovations made by Cannabix and its dual mode contactless (and traditional mouthpiece) breath capture and analysis technology. The technology can be integrated into environments such as vehicles, workplaces, or public kiosks and supports fast, reliable testing without requiring physical contact. It can be used in unmanned breath devices, offering real-time feedback through visual indicators and displays and is suited for applications in law enforcement, workplace safety, and public health monitoring. The system automatically adjusts its internal airflow and pump mechanisms based on the sampling method, ensuring accurate and hygienic analysis.
